| Tocilizumab |
Influence on tumor growth |
Tumor volume |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
p-STAT3 |
|
| Tocilizumab |
Influence on tumor growth |
Mouse weight |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
STAT3 |
|
| Tocilizumab |
Influence on tumor growth |
Survival Rate |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
| Tocilizumab |
Influence on protein activity in tumor tissue |
Western Blot |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
| Tocilizumab |
Influence on protein activity in tumor tissue |
Western Blot |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
| Tocilizumab |
Influence on protein activity in tumor tissue |
Western Blot |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
| Tocilizumab |
Influence on protein activity in tumor tissue |
Western Blot |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
| Tocilizumab |
Influence on tumor growth |
Microvessel density staining |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
| Tocilizumab |
Influence on protein activity in tumor tissue |
Western Blot |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
